Claims
- 1. A method of making a poly(propylene fumarate) network, comprising:(a) synthesizing poly(propylene fumarate)-diacrylate by reacting poly(propylene fumarate) with an acrylation reagent, or di-2-acryloxypropyl fumarate by reacting di-2-hydroxypropyl fumarate with an acrylating agent; and (b) cross-linking additional poly(propylene fumarate with the poly(propylene fumarate)-diacrylate or di-2-acryloxypropyl fumarate.
- 2. The method according to claim 1 wherein at least a portion of the poly(propylene fumarate) is made by forming di(2-hydroxylpropyl) fumarate by the reaction of fumaryl chloride with propylene glycol and transesterifying the di(2-hydroxylpropyl) fumarate.
- 3. The method according to claim 1 wherein the acrylation reagent in step (a) comprises acryloyl chloride.
- 4. The method according to claim 1 wherein the cross linked poly(propylene fumarate)-diacrylate has a compressive strength of at least 11.7 MPa.
- 5. The method according to claim 1 wherein the cross linked poly(propylene fumarate)-diacrylate has an equilibrium water content less than 1.5 percent by weight.
- 6. The method according to claim 1 wherein the poly(propylene fumarate) network degrades to a hydrophilic polymer capable of being passively excreted by human kidneys.
- 7. The method according to claim 1 wherein the cross linked poly(propylene fumarate)-diacrylate has a compressive modulus of at least 66.4 MPa.
- 8. The method according to claim 1 wherein step (b) produces a cross-linked network having the formula:
- 9. A method for forming a biocompatible implant, comprising:(a) synthesizing poly(propylene fumarate)-diacrylate by reacting poly(propylene fumarate) with an acrylation reagent or di-2-acryloxypropyl fumarate by reacting di-2-hydroxypropyl fumarate with an acrylating agent; and (b) cross-linking additional poly(propylene fumarate) with the poly(propylene fumarate)-diacrylate or di-2-acryloxypropyl fumarate so as to form a biocompatible implantable substance.
- 10. The method according to claim 9 wherein the implant, once formed, has a compressive strength at yield of at least 11.7 MPa.
- 11. The method according to claim 9 wherein the implant, once formed, has a compressive modulus of at least 66.4 MPa.
- 12. The method according to claim 9 wherein the biocompatible implantable substance degrades to a hydrophilic polymer capable of being passively excreted by human kidneys.
- 13. The method according to claim 9 wherein the biocompatible implantable substance has the formula:
- 14. The method according to claim 8 wherein m=1.
- 15. The method according to claim 8 wherein m=3.
- 16. The method according to claim 13 wherein m=1.
- 17. The method according to claim 13 wherein m=3.
CROSS-REFERENCE TO RELATED APPLICATIONS
This is a divisional application of pending U.S. patent application Ser. No. 09/549,485, filed Apr. 14, 2000, now U.S. Pat. No. 6,423,790, which claims the benefit of U.S. provisional applications Serial No. 60/129,577, filed Apr. 16, 1999, and entitled “Development of Biodegradable Bone Cement Based on Poly(Propylene Fumarate) and a Macromer,” Serial No. 60/146,991, filed Aug. 3, 1999, and entitled “Synthesis of Poly(Propylene Fumarate) by Acylation of Propylene Glycol in the Presence of a Proton Scavenger,” Serial No. 60/167,328, filed Nov. 24, 1999, and entitled “Preparation of an Injectable, in situ Polymerizable and Biodegradable Biomaterial Based On Poly(Propylene Fumarate) and Biodegradable Crosslinking Reagents,” and Serial No.60/167,388, filed Nov. 24, 1999, and entitled “Injectable Biodegradable Polymer Composites Based on Poly(Propylene Fumarate) Crosslinked with Poly(Ethylene Glycol)-Dimethacrylate and β-Tricalcium Phosphate,” all of which are incorporated herein by reference.
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
This work was funded by the National Institutes of Health R01-AR44381 and R01-DE13031.
US Referenced Citations (24)
Foreign Referenced Citations (4)
Number |
Date |
Country |
0 325 866 |
Aug 1989 |
EP |
0 580 328 |
Jan 1994 |
EP |
2 061 421 |
Dec 1970 |
NL |
WO 9529710 |
Nov 1995 |
WO |
Non-Patent Literature Citations (5)
Entry |
“Synthesis and Properties of Polymers for Biodegradable Implants”, XP-001070092; A.C. Ibay, C.E. Whalley, R.A. Miller, H. Carr, Jr., and G.C. Battistone, U.S. Army Institute of Dental Research Walter Reed Army Medical Center, Washington, D.C. 20307-5300; pp. 505-509; 1985. |
“Biodegradable Bone Cement Compositions Based on Arcylate and Epoxide Terminated Poly(propylenen Fumarate) Oligomers and Calcium Salt Compositions”, Abraham J. Domb, Nitza Manor and Omar Elmalak; The Hebrew University of Jerusalem, School of Pharmacy-Faculty of Medicine, Department of Pharmaceutical Chemistry, Jerusalem 91120, Israel; Biomaterials 1996, vol. 17 No. 4; pp. 411417; Received Jan. 3, 1994 / Accepted Apr. 24, 1995. |
Supplementary European Search Report for European Patent Application 00923355.2 dated Jul. 31, 2002 (2 p.). |
He et al., Synthesis of biodegradable poly(propylene fumarate) networks with poly(propylene fumarate)-diacrylate macromers as crosslinking agents and characterization of their degradation products; Polymer 42 (2001) 1251-1260. |
Kharas et al., Synthesis and Characterization of Fumarte-Based Polyesters for Use in Bioresorbable Bone Cement Composites; Journal of Applied Polymer Science, vol. 66, 1123-1137 (1997). |
Provisional Applications (4)
|
Number |
Date |
Country |
|
60/129577 |
Apr 1999 |
US |
|
60/146991 |
Aug 1999 |
US |
|
60/167328 |
Nov 1999 |
US |
|
60/167388 |
Nov 1999 |
US |